Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML
- Resource Type
- Article
- Authors
- Urrutia, Samuel; Bose, Prithviraj; Alvarado, Yesid; Borthakur, Gautam; Ravandi, Farhad; Daver, Naval; Pemmaraju, Naveen; Jabbour, Elias; Takahashi, Koichi; Kadia, Tapan; DiNardo, Courtney; Kornblau, Steven; Kanagal-Shamanna, Rashmi; Huang, Xuelin; Bodden, Kristy; Kantarjian, Hagop; Garcia-Manero, Guillermo
- Source
- In Blood Neoplasia June 2024 1(2)
- Subject
- Myeloid Neoplasia
Myelodysplastic Syndromes
- Language
- ISSN
- 2950-3280